302
Participants
Start Date
March 16, 2022
Primary Completion Date
June 13, 2023
Study Completion Date
September 5, 2023
Placebo Comparator
Sterile solution for subcutaneous injection
ASLAN004
Sterile solution for subcutaneous injection
ASLAN004
Sterile solution for subcutaneous injection
ASLAN004
Sterile solution for subcutaneous injection
ASLAN004
Sterile solution for subcutaneous injection
Holdsworth House Medical Practice, Sydney
Premier Specialist, Kogarah
Skin Health Institute, Carlton
Eastern Clinical Research, Box Hill
Clinical Trials NZ, Hamilton
Veracity Clinical Research, Woolloongabba
Fremantle Dermatology, Fremantle
Bobby Buka MD, PC, New York
ASLAN Investigative Site, New York
Forest Hills Dermatology Group, Kew Gardens
Clinical Research Center of the Carolinas, Charleston
ASLAN Investigative Site, Krakow
ASLAN Investigative Site, Krakow
Skin Care Physicians of Georgia, Macon
ASLAN Investigative Site, Columbus
ASLAN Investigative Site, Saint Augustine
Aby's New Generation Research, Inc., Hialeah
ASLAN Investigative Site, Hollywood
ASLAN Investigative Site, Tarnów
Driven Research, LLC, Coral Gables
ASLAN Investigative Site, North Miami Beach
Skin Research of South Florida, Miami
ASLAN Investigative Site, Miami
Encore Medical Research of Boynton Beach, Boynton Beach
Skin Care Research, LLC, Boca Raton
ASLAN Investigative Site, Tampa
ForCare Clinical Research, Tampa
ASLAN Investigative Site, Birmingham
ASLAN Investigative Site, Birmingham
ASLAN Investigative Site, Nashville
ASLAN Investigative Site, Louisville
ASLAN Investigative Site, Katowice
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
ASLAN Investigative Site, Ann Arbor
ASLAN Investigative Site, Wroclaw
ASLAN Investigative Sites, Rapid City
ASLAN Investigative Site, Baton Rouge
ASLAN Investigative Site, Little Rock
Dermatology Treatment and Research Center, Dallas
Modern Research Associates, Dallas
Menter Dermatology Research Institute, Dallas
Center for Clinical Studies LTD, LLP, Houston
ASLAN Investigative Site, San Antonio
ASLAN Investigative Site, Meridian
ASLAN Investigative Site, South Jordan
ASLAN Investigative Site, Bydgoszcz
ASLAN Investigative Site, Las Vegas
ASLAN Investigative Site, Los Angeles
ASLAN Investigative Site, Los Angeles
Clinical Science Institute, Santa Monica
ASLAN Investigative Site, Lodz
Tooraj Raoof, MD, Encino
MedDerm Associates, San Diego
ASLAN Investigative Site, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
Oregon Dermatology and Research Center, Portland
Oregon Health & Science University, Portland
ASLAN Investigative Site, Medford
Sir Ganga Ram Hospital, New Delhi
ASLAN Investigative Site, Singapore
ASLAN Investigative Site, Singapore
KK Women's and Children's Hospital, Singapore
National Skin Centre, Singapore
B. J. Medical College and Civic Hospital, Asarwa
Nirmal Hospital Pvt Ltd., Surat
D Y Patil Hospital, Navi Mumbai
Lifepoint Multispeciality Hospital, Pune
NKP Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur
King George Hospital, Visakhapatnam
Calcutta School of Tropical Medicine, Kolkata
Allcutis Research LLC, Beverly
ASLAN Investigative Site, Quincy
Clinical Partners, LLC, Johnston
Wiseman Dermatology Research, Inc., Winnipeg
DermEffects, London
ASLAN Investigative Site, Markham
Gordon Sussman Clinical Research Inc., North York
Skin Centre for Dermatology, Peterborough
Centre de Recherche Saint-Louis (Quebec), Québec
Centre de Recherche dermatologique du Quebec Metropolitain, Québec
ASLAN Investigative Site, Santo Domingo
ASLAN Investigative Site, Warsaw
ASLAN Investigative Site, Warsaw
Lead Sponsor
ASLAN Pharmaceuticals
OTHER